Cellebrite DI (CLBT) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $68583.9.
- Cellebrite DI's EPS (Weighted Average and Diluted) rose 38050.35% to $68583.9 in Q4 2025 from the same period last year, while for Dec 2025 it was $68583.9, marking a year-over-year increase of 38050.35%. This contributed to the annual value of $252664.5 for FY2025, which is 1870143876.96% up from last year.
- Cellebrite DI's EPS (Weighted Average and Diluted) amounted to $68583.9 in Q4 2025, which was up 38050.35% from $87778.3 recorded in Q3 2025.
- In the past 5 years, Cellebrite DI's EPS (Weighted Average and Diluted) ranged from a high of $389800.0 in Q2 2021 and a low of -$198255.6 during Q1 2024
- In the last 5 years, Cellebrite DI's EPS (Weighted Average and Diluted) had a median value of $53707.4 in 2022 and averaged $49877.0.
- As far as peak fluctuations go, Cellebrite DI's EPS (Weighted Average and Diluted) surged by 12178309792.7% in 2021, and later tumbled by 23936.63% in 2023.
- Cellebrite DI's EPS (Weighted Average and Diluted) (Quarter) stood at $62607.7 in 2021, then crashed by 100.0% to $0.05 in 2022, then plummeted by 239.37% to -$0.06 in 2023, then skyrocketed by 21985837.24% to $14273.3 in 2024, then skyrocketed by 380.5% to $68583.9 in 2025.
- Its EPS (Weighted Average and Diluted) was $68583.9 in Q4 2025, compared to $87778.3 in Q3 2025 and $129840.0 in Q2 2025.